Atlas Trials

Stage IV Penile Cancer AJCC v8

5 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage IV Penile Cancer AJCC v8

RecordFirmDate
Enfortumab Vedotin for the Treatment of Patients With Metastatic or Unresectable Squamous Cell Carcinoma of the Penis (NCT06104618)Mayo Clinic2023-12-21
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer (NCT04491942)National Cancer Institute (NCI)2021-08-25
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors (NCT03866382)National Cancer Institute (NCI)2019-05-13
DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers (NCT03439085)M.D. Anderson Cancer Center2018-11-14
Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors (NCT02496208)National Cancer Institute (NCI)2015-07-22

Track Stage IV Penile Cancer AJCC v8 automatically

Every clearance here is in the API, with alerts when new ones post.